Celularity

CELUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$34.156 M

$1.18 -4.84%

Close of 22 Sept 2026

Revenue

$26.6M

#2911 by revenue

Earnings

-$91.7M

Loss-making

Shares outstanding

28,945,961

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#372Rockwell MedicalRMTI$35.7M
#373BriaCell TherapeuticsBCTX$35.6M
#374CelularityCELU$34.2M
#375Quoin PharmaceuticalsQNRX$33.7M
#376Abvc BiopharmaABVC$30.9M

What if Celularity were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,044,497

Per share 885,167× higher

Bitcoin $1.74T

$60,169.19

Per share 50,991× higher

Nvidia $5.52T

$190,553.94

Per share 161,486× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Celularity are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.